You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 9, September 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic

Multiple Myeloma Invasion of the Central Nervous System

Keith O. Schluterman, MD; Athanasios B.-T. Fassas, MD; Rudy L. Van Hemert, MD; Sami I. Harik, MD

Arch Neurol. 2004;61:1423-1429.

Background  Although neurologic manifestations often complicate the course of patients with multiple myeloma (MM), direct central nervous system invasion is rare.

Objective  To describe the neurologic symptoms and signs, imaging, cerebrospinal fluid findings, and the clinical course of patients with central nervous system myeloma invasion, all of whom had leptomeningeal myelomatosis.

Design and Participants  Review of 23 patients with MM and leptomeningeal myelomatosis proven by malignant plasma cells in their cerebrospinal fluid.

Setting  Tertiary-care university medical center.

Results  Twenty-one patients had advanced-stage MM. Leptomeningeal myelomatosis was diagnosed up to 29 months (median, 13 months) after diagnosis of MM. Symptoms precipitating neurologic evaluation included manifestations of diffuse cerebral dysfunction, cranial nerve palsies, and spinal radiculopathies. Cerebrospinal fluid was abnormal in all patients, usually exhibiting pleocytosis and elevated protein content, plus positive cytologic findings. Specific magnetic resonance imaging findings suggestive of central nervous system invasion were found in 70% of the patients. These included leptomeningeal contrast enhancement and evidence of meningeal-based lesions sometimes masquerading as intraparenchymal lesions. Despite aggressive systemic and local treatment, the outcome was poor, reflecting the aggressiveness of the underlying MM.

Conclusion  Leptomeningeal myelomatosis, although rare, should be considered in patients with MM and symptoms suggestive of widespread nervous system involvement.


Author Affiliations: From the Department of Neurology (Drs Schluterman and Harik), the Myeloma Institute for Research and Therapy (Dr Fassas), and the Department of Radiology (Dr Van Hemert), University of Arkansas for Medical Sciences, Little Rock.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multifocal neuropathy due to plasma cell infiltration of peripheral nerves in multiple myeloma
Denier et al.
Neurology 2006;66:917-918.
ABSTRACT | FULL TEXT  

Commentary Regarding Neoplastic Meningitis Secondary to Multiple Myeloma
Chamberlain
Arch Neurol 2005;62:833-833.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.